Bio-Thera Solutions, Ltd. (SHA:688177)
China
· Delayed Price · Currency is CNY 21.43
-0.29 (-1.34%)
At close: Apr 25, 2025, 2:57 PM CST
Bio-Thera Solutions Revenue
In the year 2024, Bio-Thera Solutions had annual revenue of 743.17M CNY with 5.44% growth. Bio-Thera Solutions had revenue of 161.73M in the quarter ending December 31, 2024, a decrease of -33.65%.
Revenue
743.17M
Revenue Growth
+5.44%
P/S Ratio
11.94
Revenue / Employee
636.82K
Employees
1,167
Market Cap
8.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 743.17M | 38.37M | 5.44% |
| Dec 31, 2023 | 704.79M | 249.66M | 54.86% |
| Dec 31, 2022 | 455.13M | -381.45M | -45.60% |
| Dec 31, 2021 | 836.58M | 653.72M | 357.49% |
| Dec 31, 2020 | 182.86M | 182.16M | 26,023.37% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
| Aier Eye Hospital Group | 20.98B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |